G L Wollam, R W Gifford, R C Tarazi. Show Affiliations »
Abstract
Mesh: See more » Adrenergic beta-Antagonists/therapeutic useAngiotensin II/analogs & derivativesAngiotensin-Converting Enzyme InhibitorsAntihypertensive Agents/pharmacologyAntihypertensive Agents/therapeutic useClonidine/therapeutic useDiazoxide/therapeutic useDiuretics/therapeutic useGanglionic Blockers/therapeutic useHumansHydralazine/therapeutic useHypertension/drug therapyLabetalol/therapeutic useMethyldopa/therapeutic useMinoxidil/therapeutic useMonoamine Oxidase Inhibitors/therapeutic useNitroprusside/therapeutic usePotassium/metabolismPrazosin/therapeutic useSecologanin Tryptamine Alkaloids/therapeutic useSympatholytics/therapeutic use
Substances: See more » Adrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsDiureticsGanglionic BlockersMonoamine Oxidase InhibitorsSecologanin Tryptamine AlkaloidsSympatholyticsAngiotensin IINitroprussideHydralazineMethyldopaMinoxidilClonidineDiazoxideLabetalolPotassiumPrazosin
Year: 1977 PMID: 23284 DOI: 10.2165/00003495-197714060-00002
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546